Free Trial

National Health Investors (NYSE:NHI) Upgraded at Wedbush

National Health Investors logo with Finance background

Wedbush upgraded shares of National Health Investors (NYSE:NHI - Free Report) to a strong-buy rating in a report released on Wednesday morning,Zacks.com reports.

Separately, Truist Financial raised National Health Investors from a "hold" rating to a "buy" rating and set a $77.00 price objective on the stock in a research note on Wednesday. Two investment analysts have rated the stock with a hold rating, two have given a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $85.75.

View Our Latest Stock Report on National Health Investors

National Health Investors Stock Performance

NHI stock traded up $0.28 during trading hours on Wednesday, hitting $70.80. 123,629 shares of the stock were exchanged, compared to its average volume of 247,896. The firm has a market capitalization of $3.31 billion, a P/E ratio of 22.48, a P/E/G ratio of 4.27 and a beta of 0.73. National Health Investors has a 12 month low of $65.13 and a 12 month high of $86.13. The company has a current ratio of 16.55, a quick ratio of 16.55 and a debt-to-equity ratio of 0.88. The company has a 50-day simple moving average of $72.93 and a two-hundred day simple moving average of $71.59.

National Health Investors (NYSE:NHI - Get Free Report) last announced its quarterly earnings results on Monday, May 5th. The real estate investment trust reported $1.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.13 by $0.02. The company had revenue of $68.87 million for the quarter, compared to analyst estimates of $85.13 million. National Health Investors had a net margin of 41.15% and a return on equity of 10.64%. The firm's revenue was up 9.6% on a year-over-year basis. During the same period in the previous year, the firm posted $1.10 EPS. On average, analysts forecast that National Health Investors will post 4.41 earnings per share for the current fiscal year.

National Health Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 1st. Shareholders of record on Monday, June 30th will be issued a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a yield of 5.08%. The ex-dividend date is Monday, June 30th. National Health Investors's dividend payout ratio (DPR) is presently 114.29%.

Institutional Investors Weigh In On National Health Investors

A number of institutional investors and hedge funds have recently modified their holdings of the company. Strs Ohio purchased a new stake in shares of National Health Investors in the first quarter worth about $598,000. Intech Investment Management LLC lifted its holdings in shares of National Health Investors by 21.8% in the first quarter. Intech Investment Management LLC now owns 28,578 shares of the real estate investment trust's stock worth $2,111,000 after buying an additional 5,117 shares in the last quarter. Jane Street Group LLC lifted its holdings in shares of National Health Investors by 1,728.4% in the first quarter. Jane Street Group LLC now owns 69,697 shares of the real estate investment trust's stock worth $5,148,000 after buying an additional 65,885 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of National Health Investors by 9.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 249,937 shares of the real estate investment trust's stock worth $18,460,000 after buying an additional 21,851 shares in the last quarter. Finally, NewEdge Advisors LLC lifted its holdings in shares of National Health Investors by 28.7% in the first quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust's stock worth $114,000 after buying an additional 345 shares in the last quarter. 62.51% of the stock is owned by hedge funds and other institutional investors.

National Health Investors Company Profile

(Get Free Report)

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

Further Reading

Should You Invest $1,000 in National Health Investors Right Now?

Before you consider National Health Investors, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.

While National Health Investors currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines